Deployment of artificial intelligence for point-of-care clinical decision support is in its infancy. Despite media attention and proliferation of AI studies, translation to clinical practice is not ...

The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including ...

Abridge is deepening its partnership with Wolters Kluwer to embed UpToDate’s evidence-based clinical decision support directly into clinician workflows. Announced Oct. 20, the integration aims to ...

BioWorld - Tuesday, June 3, 2025 See today's BioWorld MedTech Home » Hemeo seeks protection for its AI-powered clinical decision support system To read the full story, subscribe or sign in. Patents ...

Amber Nigam is CEO and cofounder of basys.ai, a Harvard-based company streamlining prior authorization for health plans with generative AI. A few years ago, artificial intelligence (AI) promised to ...

The clinical decision support space within the broader healthcare AI market is getting more and more crowded, with startups spawning a plethora of tools that help clinicians complete a variety of ...

Technology has changed a lot since I was a practicing pharmacist. While clinicians have always focused on using technology to improve patient safety, everything else about technology is constantly ...

Clinical decision support tools have become a mainstay in many hospitals, helping clinicians identify early signs of serious conditions, flag potential deterioration and minimize medical errors. But ...

The U.S. FDA raised some hackles with its final guidance for clinical decision support (CDS) software, thanks to provisions that some stakeholders argued flew against congressional intent regarding ...

IllumiCare’s cost attribution technology defines low-value care and makes costs transparent in real time, enabling improved financial performance. Compatible with 50-plus electronic medical record ...